Skip to main content
Log in

Biochemische Knochenresorptionsmarker in der Heilungsphase osteoporotischer Frakturen

Biochemical bone resorption markers during the healing of osteoporotic fractures

  • Originalien
  • Published:
Der Unfallchirurg Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Diese Studie untersucht den Verlauf und die klinische Relevanz biochemischer Resorptionsmarker während der Frakturheilung bei Osteoporose.

Patienten und Methoden

Bei 44 Patientinnen mit distaler Radiusfraktur und 29 Patientinnen ohne Fraktur wurden die Blut- und Urinkonzentrationen von Pyridinolin (PYD), Desoxypyridinolin (DPD), N-Telopeptiden (NTx) und Bone-Sialoprotein (BSP) am Unfalltag und im Verlauf erfasst. Alle postmenopausalen Patientinnen wurden einer Knochendichtemessung unterzogen. Das Gesamtkollektiv wurde entsprechend in prämenopausal, postmenopausal osteoporotisch und postmenopausal nichtosteoporotisch eingeteilt.

Ergebnisse

Zwischen den Gruppen zeigten sich signifikante Unterschiede in den Ausgangswerten von PYD, DPD und NTx. Den weiteren relativen Verlauf beeinflusste vor allem die Art der jeweils eingeleiteten Therapie.

Schlussfolgerung

Knochenresorptionsmarker können diagnostisch Hinweise auf eine Osteoporose geben und eignen sich sehr gut als Verlaufsparameter bei der Frakturheilung.

Abstract

Background

This study investigated the progression and clinical relevance of biochemical resorption marker values during fracture healing in osteoporosis.

Patients and methods

In 44 patients with distal radius fractures and 29 patients without fractures, the blood and urine concentrations of pyridinoline (PYD), deoxypyridinoline (DPD), N-telopeptides (NTx), and bone sialoprotein (BSP) were recorded on the day of trauma as well as during further progression. All postmenopausal patients underwent bone density measurement. Accordingly, patients were divided into premenopausal, postmenopausal osteoporotic, and postmenopausal nonosteoporotic groups.

Results

Between the groups, PYD, DPD, and NTx showed significant differences in their initial values. However, their further relative progression was primarily affected by the chosen therapy.

Conclusion

Bone resorption markers can diagnostically point to osteoporosis and are significant parameters in fracture healing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Bianco P, Fisher LW, Young MF et al. (1991) Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int 49: 421–426

    Article  PubMed  CAS  Google Scholar 

  2. Bikle DD (1997) Biochemical markers in the assessment of bone disease. Am J Med 103: 427–436

    Article  PubMed  CAS  Google Scholar 

  3. Black D, Duncan A, Robins SP (1988) Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 169: 197–203

    Article  PubMed  CAS  Google Scholar 

  4. Blumsohn A, Eastell R (1997) The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice? Ann Clin Biochem 43: 449–459

    Google Scholar 

  5. Christenson RH (1997) Biochemical markers of bone metabolism: an overview. Clin Biochem 30: 573–593

    Article  PubMed  CAS  Google Scholar 

  6. Colwell A, Russell RG, Eastell R (1993) Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 23: 341–349

    Article  PubMed  CAS  Google Scholar 

  7. Consensus Development Conference (1993) Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94: 646–650

    Article  Google Scholar 

  8. Delmas PD (1991) What do we know about biochemical bone markers? Baillieres Clin Obstet Gynaecol 5: 817–830

    Article  PubMed  CAS  Google Scholar 

  9. European Commission (1998) Report on osteoporosis in the European Community – Action for prevention. Luxembourg. ISBN 92-828-5333-0

  10. Eyre DR, Koob TJ, van Ness KP (1984) Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 137: 380–388

    Article  PubMed  CAS  Google Scholar 

  11. Eyre DR (1995) The specificity of collagen cross-links as markers of bone and connective tissue degeneration. Acta Orthop Scand Suppl 266: 166–170

    PubMed  CAS  Google Scholar 

  12. Fujisawa R, Mizuno M, Nodaska Y et al. (1997) Attachment of osteoblastic cells to hydroxyapatite crystals by synthetic peptide (Glu7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein. Matrix Biol 16: 21–28

    Article  PubMed  CAS  Google Scholar 

  13. Garnero P, Delmas PD (1997) Bone markers. Baillieres Clin Rheumatol 11: 517–537

    Article  PubMed  CAS  Google Scholar 

  14. Heiss C, Hoesel LM, Wehr U et al. (2004) Vitamin K in combination with other biochemical markers to diagnose osteoporosis. Biomarkers 9: 479–488

    Article  PubMed  CAS  Google Scholar 

  15. Hoesel LM, Wehr U, Rambeck WA et al. (2005) Biochemical bone markers are useful to monitor fracture repair. Clin Orthop Relat Res 440: 226–232

    Article  PubMed  CAS  Google Scholar 

  16. Hunter GK, Goldberg HA (1994) Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J 302: 175–179

    PubMed  CAS  Google Scholar 

  17. Iacovino JR (2001) Mortality outcomes after osteoporotic fractures in men and women. J Insur Med 33: 316–320

    PubMed  CAS  Google Scholar 

  18. Leeming DJ, Alexandersen P, Karsdal MA et al. (2006) An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol 62: 781–792

    Article  PubMed  CAS  Google Scholar 

  19. Mallmin H, Ljunghall S, Larsson K (1993) Biochemical markers of bone metabolism in patients with fracture of the distal forearm. Clin Orthop Relat Res 295: 259–263

    PubMed  Google Scholar 

  20. Miyauchi A, Alvarez J, Greenfield EM et al. (1993) Binding of osteopontin to the osteoclast integrin alpha v beta 3. Osteoporos Int 3 (Suppl 1): 132–135

    Article  PubMed  Google Scholar 

  21. Raynal C, Delmas PD, Chenu C (1996) Bone sialoprotein stimulates in vitro bone resorption. Endocrinology 137: 2347–2354

    Article  PubMed  CAS  Google Scholar 

  22. Scheidt-Nave C, Ziegler R, Raspe H (1998) Epidemiologie der Osteoporose. Med Klin 93: 7–11

    Article  Google Scholar 

  23. Seibel MJ, Robins SP, Bilezikian JP (1992) Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 3: 263–270

    Article  PubMed  CAS  Google Scholar 

  24. Seibel MJ, Baylink DJ, Farley JR et al. (1997) Basic science and clinical utility of biochemical markers of bone turnover – a congress report. Exp Clin Endocrinol Diabetes 105: 125–133

    PubMed  CAS  Google Scholar 

  25. Seibel MJ (2001) Evalution des osteoporotischen Frakturrisikos. Dtsch Ärztebl 98: 1337–1342

    Google Scholar 

  26. Sirtori P, Sosio C, Polo RM et al. (1997) A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women. Pharmacol Res 36: 229–235

    Article  PubMed  CAS  Google Scholar 

  27. Thomas L (2000) Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik. TH Books GmbH, Frankfurt/Main

  28. Tromp AM, Ooms ME, Popp-Snijders C et al. (2000) Predictors of fractures in elderly women. Osteoporos Int 11: 134–140

    Article  PubMed  CAS  Google Scholar 

  29. Power M (1998) Bone markers: overuse and much abuse. Biochem Soc Trans 26: 45–47

    PubMed  CAS  Google Scholar 

  30. Woitge HW, Scheidt-Nave C, Kissling C et al. (1998) Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab 83: 68–75

    Article  PubMed  CAS  Google Scholar 

  31. WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series No. 843. Geneva

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Heiß.

Additional information

Diese Arbeit wurde im November 2003 auf der Jahrestagung der Deutschen Gesellschaft für Unfallchirurgie (DGU) in Berlin mit dem 1. Posterpreis ausgezeichnet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heiß, C., Hoesel, L., Pausch, M. et al. Biochemische Knochenresorptionsmarker in der Heilungsphase osteoporotischer Frakturen. Unfallchirurg 111, 695–702 (2008). https://doi.org/10.1007/s00113-008-1465-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00113-008-1465-1

Schlüsselwörter

Keywords

Navigation